Literature DB >> 16369953

Isolated extramedullary relapse after autologous bone marrow transplantation for acute myeloid leukemia: case report and review of the literature.

Leonardo Potenza1, Mario Luppi, Giovanni Riva, Monica Morselli, Angela Ferrari, Annalisa Imovilli, Francesca Giacobbi, Paola Temperani, Amedea Donelli, Franco Narni, Giuseppe Torelli.   

Abstract

Isolated extramedullary relapse (IEMR) is a pattern of acute myeloid leukemia (AML) relapse post-allogeneic bone marrow transplantation (alloBMT). Less is known about IEMR post-autologous BMT (autoBMT) and about factors associated with IEMR. We report a case of a woman with M4 AML who experienced IEMR post-autoBMT and review the related literature. Seventy-two alloBMT and 3 autoBMT patients, including ours, were identified. The review suggests that an M2 or M4 French-American-British (FAB) phenotype, intermediate cytogenetic risk group, and chromosome 8 abnormalities are more frequently associated with the occurrence of IEMR. IEMR occurs earlier in autoBMT than in alloBMT. Combined treatment with radiation and high-dose chemotherapy may be effective. When we searched the European Bone Marrow Transplant Registry (EBMTR) database, we found the incidence of IEMR to be statistically greater in alloBMT than in autoBMT (11% vs. 6%; P = 0.02), but no correlations have been found with the conditioning transplant regimen used. A closer follow-up, including body and central nervous system scan, should be considered in patients who are undergoing BMT presenting with several IEMR-associated factors. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16369953     DOI: 10.1002/ajh.20421

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  5 in total

1.  Characteristic patterns of relapse after allogeneic hematopoietic SCT for adult T-cell leukemia-lymphoma: a comparative study of recurrent lesions after transplantation and chemotherapy by the Nagasaki Transplant Group.

Authors:  H Itonaga; Y Sawayama; J Taguchi; S Honda; H Taniguchi; J Makiyama; E Matsuo; S Sato; K Ando; D Imanishi; Y Imaizumi; S Yoshida; T Hata; Y Moriuchi; T Fukushima; Y Miyazaki
Journal:  Bone Marrow Transplant       Date:  2015-01-26       Impact factor: 5.483

Review 2.  Chloroma of pancreas-initial manifestation of a secondary leukemia after stem cell transplantation case report and review of the literature.

Authors:  Navid Tabriz; Andrea Tannapfel; Frank Griesinger; Dirk Weyhe
Journal:  J Gastrointest Surg       Date:  2013-02-16       Impact factor: 3.452

Review 3.  Isolated extramedullary relapse in the breast of a patient with acute myeloid leukemia following allogeneic stem cell transplantation: case report and review of the literature.

Authors:  Abderrahman Abdelkefi; Lamia Torjman; Saloua Ladeb; Zeineb Sghaïer; Ramzi Jeddi; Amel Lakhal; Amr Ramzu; Amor Gamoudi; Tarek Ben Othman
Journal:  Int J Hematol       Date:  2007-02       Impact factor: 2.490

4.  Imatinib analogs as potential agents for PET imaging of Bcr-Abl and c-KIT expression at a kinase level.

Authors:  Zhenghong Peng; David S Maxwell; Duoli Sun; Basvoju A Bhanu Prasad; Ashutosh Pal; Shimei Wang; Julius Balatoni; Pradip Ghosh; Seok T Lim; Andrei Volgin; Aleksander Shavrin; Mian M Alauddin; Juri G Gelovani; William G Bornmann
Journal:  Bioorg Med Chem       Date:  2013-11-06       Impact factor: 3.641

5.  Secondary Leukemia in a non-Hodgkin's Lymphoma Patient Presenting as Myeloid Sarcoma of the Breast.

Authors:  Vincenzo Pitini; Carmela Arrigo; Maria Grazia Sauta; Giuseppe Altavilla
Journal:  Case Rep Hematol       Date:  2011-07-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.